News

• September 10, 2006
  

  C-Path Receives $675,000.00 Award for FDA Collaboration

  The Critical Path Institute (C-Path) has received $675,000 from the US Food and Drug Administration (FDA) for the first year of what is anticipated to be a multi-year, multi phased research program in cardiovascular disease.
• April 10, 2006
  

  Valley Fever Cure a Step Closer

  The federal government is backing the first potential cure for valley fever, a serious lung disease that has spiked in recent years and afflicted thousands of Arizonans.
• April 10, 2006
  

  C-Path Announces the Appointment of Jeffery Cossman, M.D., as Chief Scientific Officer

  The Critical Path Institute (C-Path), today announced the appointment of Jeffrey Cossman, M.D., an internationally recognized expert in molecular pathology, to the position of Chief Scientific Officer.
• March 10, 2006
  

  FDA Release: The Predictive Safety Testing Consortium

  The Food and Drug Administration (FDA) and The Critical Path Institute (C-Path) today announced the formation of the Predictive Safety Testing Consortium between C-Path and five of America’s largest pharmaceutical companies to share internally developed laboratory methods to predict the safety of new treatments before they are tested in humans.
• March 10, 2006
  

  C-Path Forms Drug Testing Pact

  The Tucson-based Critical Path Institute on Thursday announced an unprecedented agreement with eight major pharmaceutical companies to share drug-testing methods in an effort to improve drug safety.